Westmount, Canada

Joelle Nina Polletier

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joelle Nina Polletier: Innovator in Protein Fragment Complementation Assays

Introduction

Joelle Nina Polletier is a notable inventor based in Westmount, Canada. She has made significant contributions to the field of biomolecular interactions, particularly through her innovative patents. With a total of 2 patents, her work focuses on developing methods to detect biological or drug interactions.

Latest Patents

Polletier's latest patents include groundbreaking strategies for designing and implementing protein-fragment complementation assays (PCAs). These assays are essential for detecting biomolecular interactions both in vivo and in vitro. One of her notable inventions describes a method that involves selecting an appropriate reporter molecule, fragmenting it to cause a reversible loss of function, and then reassociating the fragments through interactions with other molecules. This innovative approach allows for the detection of various interactions, including protein-protein, protein-DNA, and protein-small molecule interactions.

Career Highlights

Joelle Nina Polletier is currently associated with Odyssey Thera Inc., where she continues to advance her research in biomolecular interactions. Her work has been instrumental in developing simple and diverse assay systems that can be applied in various biological contexts.

Collaborations

Throughout her career, Polletier has collaborated with esteemed colleagues, including Stephen William Watson Michnick and Ingrid Remy. These collaborations have further enriched her research and contributed to the advancement of her innovative methodologies.

Conclusion

Joelle Nina Polletier stands out as a pioneering inventor in the field of protein fragment complementation assays. Her contributions have the potential to significantly impact the study of biomolecular interactions and drug discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…